AU2003231279A8 - Prevention and treatment of type 2 diabetes - Google Patents

Prevention and treatment of type 2 diabetes

Info

Publication number
AU2003231279A8
AU2003231279A8 AU2003231279A AU2003231279A AU2003231279A8 AU 2003231279 A8 AU2003231279 A8 AU 2003231279A8 AU 2003231279 A AU2003231279 A AU 2003231279A AU 2003231279 A AU2003231279 A AU 2003231279A AU 2003231279 A8 AU2003231279 A8 AU 2003231279A8
Authority
AU
Australia
Prior art keywords
diabetes
prevention
treatment
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003231279A
Other versions
AU2003231279A1 (en
Inventor
Philip David Fernsten
Subramonia Padmanabha Pillai
George Rainer Siber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Wyeth LLC
Original Assignee
Wyeth Holdings LLC
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Holdings LLC, Wyeth LLC filed Critical Wyeth Holdings LLC
Publication of AU2003231279A8 publication Critical patent/AU2003231279A8/en
Publication of AU2003231279A1 publication Critical patent/AU2003231279A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003231279A 2002-04-30 2003-04-30 Prevention and treatment of type 2 diabetes Abandoned AU2003231279A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37661802P 2002-04-30 2002-04-30
US60/376,618 2002-04-30
PCT/US2003/013820 WO2003092619A2 (en) 2002-04-30 2003-04-30 Prevention and treatment of type 2 diabetes

Publications (2)

Publication Number Publication Date
AU2003231279A8 true AU2003231279A8 (en) 2003-11-17
AU2003231279A1 AU2003231279A1 (en) 2003-11-17

Family

ID=29401377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003231279A Abandoned AU2003231279A1 (en) 2002-04-30 2003-04-30 Prevention and treatment of type 2 diabetes

Country Status (2)

Country Link
AU (1) AU2003231279A1 (en)
WO (1) WO2003092619A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY144231A (en) 2003-12-17 2011-08-15 Wyeth Corp Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
CN103037891A (en) * 2010-06-03 2013-04-10 雷蒙特亚特特拉维夫大学有限公司 Methods of treating diabetes and compositions capable of same
WO2014041069A1 (en) 2012-09-12 2014-03-20 Neurimmune Holding Ag Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof
US9850302B2 (en) 2013-07-12 2017-12-26 Prothena Biosciences Limited Antibodies that recognize IAPP
US9951131B2 (en) 2013-07-12 2018-04-24 Prothena Biosciences Limited Antibodies that recognize IAPP
WO2015083125A2 (en) * 2013-12-06 2015-06-11 Prothena Biosciences Limited Antibodies that recognize iapp
BR112016021036A2 (en) * 2014-03-12 2021-06-22 Neurimmune Holding Ag new compounds capable of antagonizing ß-cell damage and impaired glucose tolerance induced by islet amyloid polypeptide (iapp)

Also Published As

Publication number Publication date
WO2003092619A3 (en) 2004-10-07
AU2003231279A1 (en) 2003-11-17
WO2003092619A2 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2003290548A8 (en) Prevention and treatment of synucleinopathic disease
TWI347188B (en) Treatment and prevention of osteoporosis
EP1399171A4 (en) Medicinal herbal compounds for the prevention and treatment of diabetes
ZA200600733B (en) Treatment and prevention of cardiovascular events
AU2003297356A8 (en) Prevention and treatment of cardiac arrhythmias
EP1489915A4 (en) Treatment and prevention of inflammatory disorders
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003268295A8 (en) "diagnosis and treatment of infertility"
GB0213869D0 (en) The treatment of pain
GB0128674D0 (en) Treatment of sleep disorders and the like
GB0211295D0 (en) Treatment of pain
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
AU2003231279A8 (en) Prevention and treatment of type 2 diabetes
LU91070B1 (en) Treatment and diagnosis of insulin resistant states
PL377110A1 (en) Prevention and treatment of alzheimer's disease
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
EP1435962A4 (en) Treatment of type i diabetes
AU2003219880A8 (en) Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
IL166083A0 (en) Methods for treatment and prevention of gastrointestinal conditions
AU2003245674A8 (en) Oral disease prevention and treatment
IL151658A0 (en) Methods and compositions for the treatment or prevention of cardiovascular diseases
AU2003237143A8 (en) Diagnosis and treatment of glaucoma
HUP0202416A3 (en) Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders
GB0217395D0 (en) Prevention and/or treatment of allergic conditions
GB0217575D0 (en) Prevention and/or treatment of allergic conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase